Holen Sie sich die Stockscreener-App
0.438
4.74%
-0.0218
Handel nachbörslich:
.43
-0.008
-1.83%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Vaxart Inc Aktie (VXRT) Neueste Nachrichten
Vaxart Announces Preliminary Results of Annual Meeting of Stockh - GuruFocus
Vaxart, Inc. Announces Results from 2025 Annual Meeting of Stockholders - Nasdaq
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders - The Manila Times
Vaxart Faces Nasdaq Challenge as Shareholders Block Reverse Split Proposal at Annual Meeting - Stock Titan
Vaxart reports improved antibody response in norovirus vaccine trial By Investing.com - Investing.com India
Biotech Steals The Mid-Week Spotlight With Key Announcement - The Globe and Mail
Vaxart (VXRT) Unveils Promising Phase 1 Results for New Noroviru - GuruFocus
Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discu - GuruFocus
Vaxart Jumps 38% After Positive Norovirus Trial - Yahoo Finance
Vaxart soars on positive data from new norovirus vaccine trial - MSN
Vaxart (VXRT) Shares Soar After Promising Norovirus Vaccine Tria - GuruFocus
Vaxart, DoubleVerify, Cracker Barrel - TradingView
Vaxart stock soars after positive Phase 1 norovirus vaccine results By Investing.com - Investing.com South Africa
Vaxart's Oral Norovirus Vaccine Pills Meet Primary Immunological Endpoint in Phase 1 Trial - marketscreener.com
Sector Update: Health Care Stocks Higher Pre-Bell Wednesday - MarketScreener
Vaxart stock soars after positive Phase 1 norovirus vaccine results - Investing.com
Vaxart reports improved antibody response in norovirus vaccine trial - Investing.com Australia
Vaxart Reports Positive Clinical Data Demonstrating that its Sec - GuruFocus
Vaxart Reports Positive Clinical Data Demonstrating Second-Generation Vaccine Technology Produces Stronger Antibody Responses Than First-Generation - marketscreener.com
Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology - The Manila Times
Vaxart Reports Positive Clinical Data Demonstrating that - GlobeNewswire
Breakthrough: New Oral Pill Vaccine Technology Delivers 141% Stronger Immune Response Against Norovirus - Stock Titan
Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial - GlobeNewswire
Vaxart to Reveal First-Ever Oral Norovirus Vaccine Trial Results: Key Data Coming Tomorrow - Stock Titan
Vaxart, Inc. (NASDAQ:VXRT) Shares Bought by Squarepoint Ops LLC - Defense World
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025 | VXRT Stock News - GuruFocus
Vaxart, Inc. (NASDAQ:VXRT) Sees Significant Increase in Short Interest - Defense World
Hagens Berman Sobol Shapiro LLP and Scott+Scott Attorneys at Law LLP Announce a Class Action for All Vaxart Shareholders that May Include You, Even if You Participated in the Previous Partial Settlement with Vaxart - Business Wire
Millennium Management LLC Decreases Stock Holdings in Vaxart, Inc. (NASDAQ:VXRT) - Defense World
Vaxart Announces Adjournment of Annual Meeting of Stockholders | - GuruFocus
Vaxart Announces Adjournment Of Annual Meeting Of Stockholders - marketscreener.com
Vaxart Announces Adjournment of Annual Meeting of Stockholders | VXRT Stock News - GuruFocus
Vaxart Annual Meeting Adjourned to June 13, 2025; Proxy Advisory Firms Support Proposal No. 2 - Nasdaq
Vaxart Announces Adjournment of Annual Meeting of Stockholders - GlobeNewswire
B. Riley Has Positive Forecast for Vaxart Q3 Earnings - Defense World
FY2029 Earnings Estimate for Vaxart Issued By B. Riley - Defense World
Vaxart stock climbs on positive study of pill-based norovirus vaccine - MSN
Zoom Rises 8% in 3 Months: Here's Why You Should Buy the Stock Now - The Globe and Mail
Vaxart seeks shareholder nod for reverse stock split By Investing.com - Investing.com South Africa
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025 - The Manila Times
Vaxart Leaders Set for Key Fireside Chat at Major Healthcare Conference: What to Expect - Stock Titan
Vaxart (VXRT) Releases Video Update Urging Support for Reverse S - GuruFocus
Vaxart seeks shareholder nod for reverse stock split - Investing.com Australia
Vaxart's Founder and Chief Scientific Officer Provides Video Update to Stockholders | VXRT Stock News - GuruFocus
Vaxart’s Founder and Chief Scientific Officer Provides Video Update to Stockholders - GlobeNewswire
Vaxart Founder Makes Urgent Appeal: Critical Nasdaq Compliance Vote Deadline Approaches - Stock Titan
Vaxart Discusses Reverse Stock Split and Capital Raise - TipRanks
Vaxart Answers Additional Frequently Asked Questions from Retail Investors - GlobeNewswire
Vaxart (VXRT) Addresses Stockholder Concerns Ahead of Annual Mee - GuruFocus
Vaxart Begins Phase 2b Trial for Oral COVID-19 Vaccine - TipRanks
Vaxart (VXRT) Addresses Stockholder Concerns Ahead of Annual Meeting | VXRT Stock News - GuruFocus
Vaxart Reveals New Split Ratio Details as Nasdaq Delisting Deadline LoomsCEO Urges Action - Stock Titan
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):